» Articles » PMID: 33970534

Staphylococcus Aureus ST228 and ST239 As Models for Expression Studies of Diverse Markers During Osteoblast Infection and Persistence

Overview
Specialty Microbiology
Date 2021 May 10
PMID 33970534
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The ability of S. aureus to infect bone and osteoblasts is correlated with its incredible virulence armamentarium that can mediate the invasion/internalization process, cytotoxicity, membrane damage, and intracellular persistence. We comparatively analyzed the interaction, persistence, and modulation of expression of selected genes and cell viability in an ex vivo model using human MG-63 osteoblasts of two previously studied and well-characterized S. aureus clinical strains belonging to the ST239-SCCmecIII-t037 and ST228-SCCmecI-t041 clones at 3 h and 24 h post-infection (p.i). S. aureus ATCC12598 ST30-t076 was used as a control strain. Using imaging flow cytometry (IFC), we found that these strains invaded and persisted in MG-63 osteoblasts to different extents. The invasion was evaluated at 3 h p.i and persistence at 24 h p.i., in particular: ATCC12598 internalized in 70% and persisted in 50% of MG-63 cells; ST239-SCCmecIII internalized in 50% and persisted in 45% of MG-63 cells; and ST228-SCCmecI internalized in 30% and persisted in 20% of MG-63 cells. During the infection period, ST239-III exerted significant cytotoxic activity resulting from overexpression of hla and psmA and increased expression of the genes involved in adhesion, probably due to the release and re-entry of bacteria inside MG-63 cells at 24 h p.i. The lower invasiveness of ST228-I was also associated with non-cytotoxic activity inside osteoblasts. This clone was unable to activate sufficient cellular reaction and succumbed inside MG-63 cells. Our findings support the idea of considering new strategies, based on a translational approach-eukaryotic host-pathogen interaction (EHPI)-and to be applied on a large scale, to predict S. aureus /osteoblast interaction and treat bone infections. Such strategies rely on the study of the genetic and biochemical basis of both pathogen and host.

Citing Articles

Characterizing oxidative stress induced by Aβ oligomers and the protective role of carnosine in primary mixed glia cultures.

Cardaci V, Di Pietro L, Zupan M, Sibbitts J, Privitera A, Lunte S Free Radic Biol Med. 2025; 229:213-224.

PMID: 39824445 PMC: 11895860. DOI: 10.1016/j.freeradbiomed.2025.01.030.


A Novel Approach Based on Real-Time PCR with High-Resolution Melting Analysis for the Simultaneous Identification of and .

Chieffi D, Bongiorno D, Licitra A, Campanile F, Fusco V Foods. 2024; 13(18).

PMID: 39335932 PMC: 11431256. DOI: 10.3390/foods13183004.


Generation and Characterization of Stable Small Colony Variants of USA300 in RAW 264.7 Murine Macrophages.

Bivona D, Bonomo C, Colombini L, Bonacci P, Privitera G, Caruso G Antibiotics (Basel). 2024; 13(3).

PMID: 38534699 PMC: 10967292. DOI: 10.3390/antibiotics13030264.


A high-throughput cytotoxicity screening platform reveals -independent mutations in bacteraemia-associated that promote intracellular persistence.

Hachani A, Giulieri S, Guerillot R, Walsh C, Herisse M, Soe Y Elife. 2023; 12.

PMID: 37289634 PMC: 10259494. DOI: 10.7554/eLife.84778.


In Silico Genome-Scale Analysis of Molecular Mechanisms Contributing to the Development of a Persistent Infection with Methicillin-Resistant (MRSA) ST239.

Dmitrenko O, Chaplin A, Balbutskaya A, Pkhakadze T, Alkhovsky S Int J Mol Sci. 2022; 23(24).

PMID: 36555727 PMC: 9781258. DOI: 10.3390/ijms232416086.


References
1.
Oliveira D, Borges A, Simoes M . Toxins and Their Molecular Activity in Infectious Diseases. Toxins (Basel). 2018; 10(6). PMC: 6024779. DOI: 10.3390/toxins10060252. View

2.
Romilly C, Lays C, Tomasini A, Caldelari I, Benito Y, Hammann P . A non-coding RNA promotes bacterial persistence and decreases virulence by regulating a regulator in Staphylococcus aureus. PLoS Pathog. 2014; 10(3):e1003979. PMC: 3961350. DOI: 10.1371/journal.ppat.1003979. View

3.
Tong S, Davis J, Eichenberger E, Holland T, Fowler Jr V . Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015; 28(3):603-61. PMC: 4451395. DOI: 10.1128/CMR.00134-14. View

4.
Tajima A, Iwase T, Shinji H, Seki K, Mizunoe Y . Inhibition of endothelial interleukin-8 production and neutrophil transmigration by Staphylococcus aureus beta-hemolysin. Infect Immun. 2008; 77(1):327-34. PMC: 2612281. DOI: 10.1128/IAI.00748-08. View

5.
Campanile F, Bongiorno D, Perez M, Mongelli G, Sessa L, Benvenuto S . Epidemiology of Staphylococcus aureus in Italy: First nationwide survey, 2012. J Glob Antimicrob Resist. 2016; 3(4):247-254. DOI: 10.1016/j.jgar.2015.06.006. View